These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16077390)

  • 1. Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy.
    Kondoh H; Sawa Y; Fukushima N; Matsumiya G; Miyagawa S; Kitagawa-Sakakida S; Memon IA; Kawaguchi N; Matsuura N; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):295-302. PubMed ID: 16077390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.
    Kondoh H; Sawa Y; Miyagawa S; Sakakida-Kitagawa S; Memon IA; Kawaguchi N; Matsuura N; Shimizu T; Okano T; Matsuda H
    Cardiovasc Res; 2006 Feb; 69(2):466-75. PubMed ID: 16423569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined strategy using myoblasts and hepatocyte growth factor in dilated cardiomyopathic hamsters.
    Kondoh H; Sawa Y; Fukushima N; Matsumiya G; Miyagawa S; Kitagawa-Sakakida S; Imanishi Y; Kawaguchi N; Matsuura N; Matsuda H
    Ann Thorac Surg; 2007 Jul; 84(1):134-41. PubMed ID: 17588400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart.
    Iwata K; Sawa Y; Kitagawa-Sakakida S; Kawaguchi N; Matsuura N; Nakamura T; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):719-25. PubMed ID: 16153919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of N-cadherin in hepatocyte growth factor (HGF) mediated improvement of the cardiac function of dilated cardiomyopathy mice.
    Tang Q; Shen D; Huang Z; Xiong R; Wu H; Huang J; Feng S; Niu P; Yang L; Bian Z
    Int J Cardiol; 2008 Jul; 127(3):442-3. PubMed ID: 18495274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
    Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
    Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment using insulin-like growth factor-1 (IGF-1) improves life expectancy of the delta-sarcoglycan deficient hamster.
    Serose A; Salmon A; Fiszman MY; Fromes Y
    J Gene Med; 2006 Aug; 8(8):1048-55. PubMed ID: 16779861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty].
    Miyagawa S; Sawa Y; Taketani S; Kawaguchi N; Nakamura T; Matsuura N; Matsuda H
    J Cardiol; 2003 Jan; 41(1):36-8. PubMed ID: 12564112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of gene transfer with hepatocyte growth factor for pulmonary vascular hypoplasia in neonatal porcine model.
    Ono M; Sawa Y; Miyamoto Y; Fukushima N; Ichikawa H; Ishizaka T; Kaneda Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):740-5. PubMed ID: 15821638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.
    Bové T; Van Belleghem Y; Vandenplas G; Caes F; François K; De Backer J; De Pauw M; Van Nooten G
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):995-1003; discussion 1003. PubMed ID: 19136274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.
    Liu X; Gu X; Li Z; Li X; Li H; Chang J; Chen P; Jin J; Xi B; Chen D; Lai D; Graham RM; Zhou M
    J Am Coll Cardiol; 2006 Oct; 48(7):1438-47. PubMed ID: 17010808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart.
    Hoashi T; Matsumiya G; Miyagawa S; Ichikawa H; Ueno T; Ono M; Saito A; Shimizu T; Okano T; Kawaguchi N; Matsuura N; Sawa Y
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):460-7. PubMed ID: 19619796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of cell-cell adhesion in an inbred strain of hereditary cardiomyopathic hamster (Bio 14.6).
    Fujio Y; Yamada-Honda F; Sato N; Funai H; Wada A; Awata N; Shibata N
    Cardiovasc Res; 1995 Dec; 30(6):899-904. PubMed ID: 8746204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy.
    Sun CK; Chang LT; Sheu JJ; Chiang CH; Lee FY; Wu CJ; Chua S; Fu M; Yip HK
    Crit Care Med; 2009 Apr; 37(4):1197-205. PubMed ID: 19242323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.
    Nakamura T; Matsumoto K; Mizuno S; Sawa Y; Matsuda H; Nakamura T
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2131-9. PubMed ID: 15840903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.